AstraZeneca To Accelerate Clinical Studies, New Drug Launches In Japan
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca plans to speed up clinical trials for diabetic and cancer drugs, aiming for earlier product launches in Japan, disclosed Osaka-based AstraZeneca Japan President Masuhiro Kato